These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14967844)

  • 1. From inflammation to fibrosis: a stiff stretch of highway.
    Weber KT
    Hypertension; 2004 Apr; 43(4):716-9. PubMed ID: 14967844
    [No Abstract]   [Full Text] [Related]  

  • 2. Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.
    Tokuda K; Kai H; Kuwahara F; Yasukawa H; Tahara N; Kudo H; Takemiya K; Koga M; Yamamoto T; Imaizumi T
    Hypertension; 2004 Feb; 43(2):499-503. PubMed ID: 14699000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of intercellular adhesion molecule-1 in hypertensive cardiac remodeling.
    Kuwahara F; Kai H; Tokuda K; Niiyama H; Tahara N; Kusaba K; Takemiya K; Jalalidin A; Koga M; Nagata T; Shibata R; Imaizumi T
    Hypertension; 2003 Mar; 41(3 Pt 2):819-23. PubMed ID: 12624002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone.
    Sun Y; Ratajska A; Zhou G; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):395-403. PubMed ID: 8228553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: involvement of tenascin-C induced by aldosterone-mediated inflammation.
    Nishioka T; Suzuki M; Onishi K; Takakura N; Inada H; Yoshida T; Hiroe M; Imanaka-Yoshida K
    J Cardiovasc Pharmacol; 2007 May; 49(5):261-8. PubMed ID: 17513943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib, but not rofecoxib or naproxen, attenuates cardiac hypertrophy and fibrosis induced in vitro by angiotensin and aldosterone.
    Wang BH; Bertucci MC; Ma JY; Adrahtas A; Cheung RY; Krum H
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):912-8. PubMed ID: 20497423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.
    Zia AA; Kamalov G; Newman KP; McGee JE; Bhattacharya SK; Ahokas RA; Sun Y; Gerling IC; Weber KT
    Hypertens Res; 2010 Nov; 33(11):1091-101. PubMed ID: 20827279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
    Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
    Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in renovascular hypertensive rats.
    Kawai M; Hongo K; Komukai K; Morimoto S; Nagai M; Seki S; Taniguchi I; Mochizuki S; Yoshimura M
    Hypertens Res; 2009 Jul; 32(7):604-10. PubMed ID: 19424279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cardiac fibrosis by aldosterone.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
    Gao Y; Gao J; Chen C; Wang H; Guo J; Wu R
    Planta Med; 2015 May; 81(7):568-77. PubMed ID: 25905591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.
    Rocha R; Martin-Berger CL; Yang P; Scherrer R; Delyani J; McMahon E
    Endocrinology; 2002 Dec; 143(12):4828-36. PubMed ID: 12446610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis in hypertensive heart disease: an overview of potential regulatory mechanisms.
    Weber KT; Sun Y; Guarda E; Katwa LC; Ratajska A; Cleutjens JP; Zhou G
    Eur Heart J; 1995 May; 16 Suppl C():24-8. PubMed ID: 7556268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profibrotic effects of angiotensin II in the heart: a matter of mediators.
    Díez J
    Hypertension; 2004 Jun; 43(6):1164-5. PubMed ID: 15117918
    [No Abstract]   [Full Text] [Related]  

  • 16. Ageing related periostin expression increase from cardiac fibroblasts promotes cardiomyocytes senescent.
    Li Q; Liu X; Wei J
    Biochem Biophys Res Commun; 2014 Sep; 452(3):497-502. PubMed ID: 25173938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.
    Kuster GM; Kotlyar E; Rude MK; Siwik DA; Liao R; Colucci WS; Sam F
    Circulation; 2005 Feb; 111(4):420-7. PubMed ID: 15687129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial fibrosis associated with aldosterone or angiotensin II administration: attenuation by calcium channel blockade.
    Ramires FJ; Sun Y; Weber KT
    J Mol Cell Cardiol; 1998 Mar; 30(3):475-83. PubMed ID: 9515025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension-induced fibrosis: a balance story].
    Azibani F; Fazal L; Chatziantoniou C; Samuel JL; Delcayre C
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):150-5. PubMed ID: 22681982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of cardiac fibroblast function.
    Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
    Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.